Hepatitis Monthly

Published by: Neoscriber Demo Publisher

Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran

Seyed Moayed Alavian 1 , * , Masoud Ahmadzad Asl 2 , maryam keshvari 3 , Bita Behnava 4 and bashir hajibeigi 5
Authors Information
1 Department of Gastroenterology, Baqiyatallah University of Medical Sciences , Dean of Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
2 Methodology and Statistics Consultant, Nikan Health Researchers Institute, Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
3 Infectious Specialist, Blood Transfusion Research Center, Iran Blood Transfusion Organization, Tehran, Tehran, IR.Iran
4 Infectious Specialist, Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
5 Blood Transfusion Research Center, Iran Blood Transfusion Organization, Tehran, Tehran, IR.Iran
Article information
  • Hepatitis Monthly: June 30, 2006, 6 (1); e92946
  • Published Online: March 31, 2006
  • Article Type: Research Article
  • Received: May 05, 2019
  • Accepted: March 31, 2006

To Cite: Alavian S M, Ahmadzad Asl M, keshvari M, Behnava B, hajibeigi B. Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran, Hepat Mon. 2006 ; 6(1):e92946.

Abstract
© 2006, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Fulltext
References
  • 1. The references are available in the PDF file.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments